Findings

Congress finds the following: (1) Ovarian cancer remains one of the deadliest gynecologic cancers and is frequently diagnosed at an advanced stage. (2) Early recognition of symptoms, access to genetic counseling and testing, and timely referral to specialized care can improve outcomes for individuals diagnosed with ovarian cancer. (3) Significant disparities persist in access to gynecologic oncology services, genetic counseling, hereditary cancer risk assessment, and specialty care, particularly in rural and medically underserved communities. (4) Advances in genetic and genomic science present significant opportunities to improve prevention, early detection, treatment selection, and survivorship outcomes. (5) Hereditary cancer syndromes, including hereditary breast and ovarian cancer syndrome and Lynch syndrome, contribute significantly to ovarian cancer risk and may first be identified following a diagnosis of endometrial cancer. (6) Evidence-based genetic counseling and testing can inform treatment decisions, guide preventive interventions, and identify at-risk family members who may benefit from surveillance or risk-reducing care. (7) Increased public education, provider awareness, and access to specialty care are essential to improving outcomes for individuals affected by ovarian cancer and hereditary cancer syndromes.